GANIRELIX GEDEON RICHTER (Gedeon Richter Australia Pty Ltd)
Product name
GANIRELIX GEDEON RICHTER
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
101 (175 working days)
Active ingredients
ganirelix acetate
Registration type
New generic medicine
Indication
For the prevention of premature luteinisation and ovulation in patients undergoing controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques.